← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV21행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
Overview
Program
Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
Overview
Company
Henry Ford Health System
Overview
Modality
CGT
Overview
Target
FRα
Overview
Indication
Malignant Glioma of Brain; Astrocytoma
Overview
Phase
PHASE_1
Overview
Status
RECRUITING
MoA
Mechanism
- binding to DNA in mitochondria with pH values above 8
MoA
Biomarker
biomarkers in fibrotic kidneys: lysyl oxidase-derived allysine (Lys Ald ) and transglutaminase 2 (TG2)
PK/PD
Species
Rat
PK/PD
Animal (cat.)
Rat
PK/PD
Experiment
PK
Toxicology
Species
Rat
Toxicology
Animal (cat.)
Rat
Toxicology
Major finding
Tumor control probability modeling of stereotactic radiosurgery and fractionated stereotactic radiosurgery for patients with brainstem metastases.. Evidence supports stereotactic radiosurgery (SRS) or fractionated stereotactic radiosurgery (fSRS) for brainstem metastases (BSMs). The optimal dose-fractionation schedule remains undefined. We evaluated tumor control probability (TCP), overall surviva…
Clinical
PFS
5
Clinical
OS
5
Clinical
Result source
ClinicalTrials.gov NCT04588246
Clinical
Data Tier / Score
A · 29
Clinical
Program phase
PHASE_1
Clinical
Clinical sync
2026년 7월 13일 (1일 전)